- Home
- HRTX vs ASPI Comparison
HRTX vs ASPI Comparison
Compare HRTX & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- ASPI
- Stock Information
- Founded
- HRTX 1983
- ASPI 2021
- Country
- HRTX United States
- ASPI United States
- Employees
- HRTX N/A
- ASPI N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- ASPI Major Chemicals
- Sector
- HRTX Health Care
- ASPI Industrials
- Exchange
- HRTX Nasdaq
- ASPI Nasdaq
- Market Cap
- HRTX 180.5M
- ASPI 158.4M
- IPO Year
- HRTX 1987
- ASPI 2022
- Fundamental
- Price
- HRTX $1.06
- ASPI $7.71
- Analyst Decision
- HRTX Strong Buy
- ASPI Strong Buy
- Analyst Count
- HRTX 3
- ASPI 2
- Target Price
- HRTX $5.67
- ASPI $4.50
- AVG Volume (30 Days)
- HRTX 2.1M
- ASPI 8.3M
- Earning Date
- HRTX 11-12-2024
- ASPI 12-03-2024
- Dividend Yield
- HRTX N/A
- ASPI N/A
- EPS Growth
- HRTX N/A
- ASPI N/A
- EPS
- HRTX N/A
- ASPI N/A
- Revenue
- HRTX $137,737,000.00
- ASPI $3,383,374.00
- Revenue This Year
- HRTX $19.15
- ASPI $1,760.86
- Revenue Next Year
- HRTX $21.29
- ASPI $314.74
- P/E Ratio
- HRTX N/A
- ASPI N/A
- Revenue Growth
- HRTX 12.13
- ASPI N/A
- 52 Week Low
- HRTX $1.04
- ASPI $1.65
- 52 Week High
- HRTX $3.93
- ASPI $9.33
- Technical
- Relative Strength Index (RSI)
- HRTX 23.07
- ASPI 59.78
- Support Level
- HRTX $1.04
- ASPI $6.75
- Resistance Level
- HRTX $1.90
- ASPI $8.15
- Average True Range (ATR)
- HRTX 0.13
- ASPI 1.07
- MACD
- HRTX -0.05
- ASPI -0.18
- Stochastic Oscillator
- HRTX 2.33
- ASPI 44.71
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.